S P Gabbita1, M Y Aksenov, M A Lovell
1Sanders-Brown Center on Aging, University of Kentucky, Lexington 40536-0230, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Alzheimer's disease (AD) shows reduced activity of peptide, methionine sulfoxide reductase (MsrA), an antioxidant enzyme. This decline in MsrA activity may impair brain antioxidant defenses, contributing to AD pathophysiology.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: